Reckitt CEO's $17B Predicament Post author:Sam Post published:December 26, 2017 Post category:BioPharma 2018 is the year for Rakesh Kapoor to show he’s worth it. Source: BioSpace You Might Also Like Finally! STADA Arzneimittel Accepts $5.6 Billion Takeover Offer From Cinven April 9, 2017 3 Biotechs the Super-Rich Regret Buying in 2017 (So Far) March 22, 2017 AntriaBio Announces $13 Million Close Of Private Placement Transaction And Plan To Dose First Patient With AB101 This Month July 17, 2017
AntriaBio Announces $13 Million Close Of Private Placement Transaction And Plan To Dose First Patient With AB101 This Month July 17, 2017
